AgomAb Therapeutics NV American Depositary Shares (AGMB) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for AGMB. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 34 institutions reported holding AGMB, with 26.0 million shares worth $337.0 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Eqt Fund Management S.a R.L | 5,141,992 | $67M | UNCHANGED |
| Sanofi | 2,783,096 | $36M | UNCHANGED |
| Redmile Group | 2,733,926 | $35M | INCREASED |
| Cormorant Asset Management | 2,465,348 | $32M | UNCHANGED |
| Tcg Crossover Management | 2,053,233 | $27M | UNCHANGED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| David R Epstein (Director) | BUY | 5,000 | $35K | 2026-11-05 |
| David R Epstein (Director) | BUY | 5,000 | $35K | 2026-11-05 |
| David R Epstein (Director) | BUY | 5,000 | $34K | 2026-11-05 |
| David R Epstein (Director) | BUY | 5,000 | $45K | 2026-10-21 |
| David R Epstein (Director) | BUY | 5,000 | $44K | 2026-10-21 |
Full institutional holdings, insider history, and congressional trades for AgomAb Therapeutics NV American Depositary Shares on SentiSense.